Michelle Combs
About Michelle Combs
Michelle Combs is the Executive Vice President of Data Management and Biometrics with over 20 years of experience in clinical development, specializing in early clinical research and innovative study designs.
Michelle Combs Executive Vice President Data Management and Biometrics
Michelle Combs serves as the Executive Vice President of Data Management and Biometrics. With over 20 years of experience in clinical development, she has a robust background in areas critical to the field. Her work primarily centers on safety, tolerability, pharmacokinetics, and the efficacy of new compounds and formulations. She has dedicated the last 17 years to early clinical research, emphasizing the automation of data delivery and innovative study designs, including adaptive trials.
Michelle Combs Education and Expertise
Michelle Combs holds an M.S. and Ph.D. in Biostatistics from the University of Iowa. Her educational background also includes a B.S. in Mathematics and Statistics from the University of Nebraska at Kearney. Her expertise spans biostatistics, pharmacokinetics, and clinical trial data management. This foundation has enabled her to contribute significantly to the fields of clinical development and early clinical research.
Michelle Combs Clinical Research Background
Michelle Combs has an extensive background in clinical research. She joined MDS Harris in 1997 and has held positions of increasing responsibility in biostatistics and pharmacokinetics. At MDS Pharma Services, she led the Global Clinical Pharmacology Sciences department. Her research credentials include working at the University of Iowa Clinical Trials Data Management Center, where she participated in planning, analyzing, and interpreting several Phase III clinical trials.
Michelle Combs Achievements in Data Management and Biometrics
Throughout her career, Michelle Combs has focused on the automation of data delivery and innovative study designs. Her work includes developing adaptive trials and integrating new technologies into clinical research. Her dedication to early clinical research and her leadership roles in biostatistics and pharmacokinetics have positioned her as an expert in Data Management and Biometrics within the industry.